| |
 |
|
Class Information
Number: 424/236.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.)
Description: Subject matter involving a bacterial toxin or toxoid, except an endotoxin.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6472183 |
Immunity against Actinobacillus pleuropneumoniae's RTX toxins APX |
Oct. 29, 2002 |
| 6464986 |
Method for treating pain by peripheral administration of a neurotoxin |
Oct. 15, 2002 |
| 6461617 |
Recombinant toxin fragments |
Oct. 8, 2002 |
| 6458365 |
Method for treating headache |
Oct. 1, 2002 |
| 6455673 |
Multi-mutant diphtheria toxin vaccines |
Sep. 24, 2002 |
| 6447777 |
Polymerized staphylococcal protein a for treatment of diseases |
Sep. 10, 2002 |
| 6448231 |
Method and compositions for the treatment of cerebral palsy |
Sep. 10, 2002 |
| 6447787 |
Methods for enhancing wound healing |
Sep. 10, 2002 |
| 6447785 |
Method for treating hypercalcemia |
Sep. 10, 2002 |
| 6440423 |
Mutant enterotoxin effective as a non-toxic oral adjuvant |
Aug. 27, 2002 |
| 6436407 |
Mutant enterotoxin effective as a non-toxic adjuvant |
Aug. 20, 2002 |
| 6426075 |
Protease-activatable pseudomonas exotoxin A-like proproteins |
Jul. 30, 2002 |
| 6423319 |
Methods for treating muscle injuries |
Jul. 23, 2002 |
| 6423513 |
Polynucleotides encoding protease-activatable pseudomonas exotoxin a-like proproteins |
Jul. 23, 2002 |
| 6416765 |
Neurotoxin therapy for diabetes |
Jul. 9, 2002 |
| 6416968 |
Methods of inhibiting Helicobacter pylori |
Jul. 9, 2002 |
| 6413523 |
Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant and methods of use |
Jul. 2, 2002 |
| 6410022 |
Modulation of cholesteryl ester transfer protein (CETP) activity |
Jun. 25, 2002 |
| 6410024 |
Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
Jun. 25, 2002 |
| 6403094 |
Clostridium perfringens vaccines |
Jun. 11, 2002 |
| 6399076 |
Acellular pertussis vaccines and methods of preparation thereof |
Jun. 4, 2002 |
| 6395282 |
Immunogenic conjugates of Gram-negative bacterial autoinducer molecules |
May. 28, 2002 |
| 6395277 |
Method and compositions for the treatment of cerebral palsy |
May. 28, 2002 |
| 6391315 |
Vaccine for inhibiting and preventing induced staphylococcus infection, isolated antigens used therein, and isolated antibodies induced thereby |
May. 21, 2002 |
| 6387377 |
Acellular antibordetella vaccine |
May. 14, 2002 |
| 6383509 |
Biodegradable neurotoxin implant |
May. 7, 2002 |
| 6379677 |
Streptococcus iniae vaccine |
Apr. 30, 2002 |
| 6372226 |
Intraspinal botulinum toxin for treating pain |
Apr. 16, 2002 |
| 6372222 |
Antigenic group B Streptococcus type II and type III polysaccharide fragments having a 2, 5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
Apr. 16, 2002 |
| 6372225 |
Tetanus toxin functional fragment antigen and tetanus vaccine |
Apr. 16, 2002 |
| 6368605 |
Method for treating cancer with a neurotoxin to improve patient function |
Apr. 9, 2002 |
| 6365158 |
Methods for producing neutralizing antitoxin to C. difficile toxin B |
Apr. 2, 2002 |
| 6365163 |
Immunological tolerance-inducing agent |
Apr. 2, 2002 |
| 6365164 |
Use of neurotoxin therapy for treatment of urologic and related disorders |
Apr. 2, 2002 |
| 6358513 |
Method for treating Hashimoto's thyroiditis |
Mar. 19, 2002 |
| 6350455 |
Method for treating a catecholamine secretion |
Feb. 26, 2002 |
| 6342231 |
Haemophilus parasuis vaccine and diagnostic |
Jan. 29, 2002 |
| 6337075 |
Methods for treating diabetes |
Jan. 8, 2002 |
| 6333037 |
Methods for treating pain with a modified neurotoxin |
Dec. 25, 2001 |
| 6322796 |
Immunological tolerance-inducing agent |
Nov. 27, 2001 |
| 6319505 |
Method for treating dystonia with botulinum toxin types C to G |
Nov. 20, 2001 |
| 6315984 |
Pressurized container having an aerosolized pharmaceutical composition |
Nov. 13, 2001 |
| 6312708 |
Botulinum toxin implant |
Nov. 6, 2001 |
| 6306423 |
Neurotoxin implant |
Oct. 23, 2001 |
| 6299881 |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
Oct. 9, 2001 |
| 6290961 |
Method for treating dystonia with botulinum toxin type B |
Sep. 18, 2001 |
| 6291516 |
Regulators of the hedgehog pathway, compositions and uses related thereto |
Sep. 18, 2001 |
| 6267966 |
Vaccine production of the Bacillus anthracis protective antigen |
Jul. 31, 2001 |
| 6265379 |
Method for treating otic disorders |
Jul. 24, 2001 |
| 6261572 |
Method for treating a pancreatic disorder with a neurotoxin |
Jul. 17, 2001 |
|
|
|
